Guard Therapeutics International AB (publ) (STO:GUARD)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.140
-0.040 (-1.87%)
Jan 21, 2026, 5:01 PM CET
-89.25%
Market Cap43.16M
Revenue (ttm)n/a
Net Income (ttm)-118.48M
Shares Out20.17M
EPS (ttm)-7.38
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,591
Average Volume91,856
Open2.190
Previous Close2.140
Day's Range2.020 - 2.240
52-Week Range1.100 - 34.800
Beta-0.34
RSI50.65
Earnings DateFeb 20, 2026

About STO:GUARD

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is ba... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Nasdaq Stockholm
Ticker Symbol GUARD
Full Company Profile

Financial Performance

Financial Statements